Announcements Trials
Browse Landscape

Phase

Phase 1 39Phase 1/2 21Phase 2 17Phase NA 9Phase 3 6Phase EARLY_PHASE1 5Phase 4 2Phase 2/3 1

Status

Completed 1954Active not recruiting 512Recruiting 490Terminated 420Unknown 173Not yet recruiting 113Withdrawn 102Suspended 6Enrolling by invitation 6

Sponsor Class

OTHER 19INDUSTRY 6NIH 3OTHER_GOV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 2Thoracic 1Gynecologic 1CNS 1

Conditions

Triple Negative Breast Neoplasms 2Tissue Adhesions 1Ovarian Cysts 1Neoplasms 1NSCLC 1Glioblastoma 1Endometriosis 1Cachexia 1

Interventions

Paclitaxel 2MBT-0206 1HM781-36B 1Gemcitabine 1Docetaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Suspended × INDUSTRY × Clear all
NCT05378763 2026-05-22

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended
268 enrolled
Thoracic

NSCLC

NCT02546102 2024-04-03

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

Precision Life Sciences Group

Phase 3 Suspended
234 enrolled
CNS

Glioblastoma

NCT03002103 2023-04-26

A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer

SynCore Biotechnology Co., Ltd.

Phase 3 Suspended
420 enrolled
Breast

Triple Negative Breast Neoplasms

NCT04001010 2021-02-05

SERENITY

Tetra Bio-Pharma

Phase 3 Suspended
334 enrolled

Cachexia, Neoplasms

NCT03777579 2019-08-08

A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 3 Suspended
375 enrolled
Breast

Triple Negative Breast Neoplasms

NCT00865488 2009-12-23

Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery

OMRIX Biopharmaceuticals

Phase 3 Suspended
80 enrolled
Gynecologic

Tissue Adhesions, Endometriosis, Ovarian Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡